Peptide News Digest

#Orthopaedic-Peptide

2 stories

Research · View digest

Columbia Study of 300 Google Results on Orthopedic Peptides Finds Most Questions Ask How BPC-157 Works and What Its Risks Are

Orthopedic surgeons at NewYork-Presbyterian/Columbia ran three Google searches on peptide therapy in orthopedics, mainly BPC-157, and analyzed 300 "People also ask" questions and their linked websites. Structure and function (31.7%) and risks and complications (20.7%) were the top question topics, and websites averaged 2.0 of 4 on the JAMA benchmark criteria for source quality, with government sites (mostly PubMed articles) scoring 3.6 and medical practice and single-surgeon sites 0.7, the paper in Arthroscopy, Sports Medicine, and Rehabilitation reports. The authors advise doctors to discuss evidence quality when talking about peptides.

Research · View digest

PubMed Review: "Therapeutic Peptides in Orthopaedics — Applications, Challenges, and Future Directions"

A 2025-2026 PubMed-indexed review (PMID 41490200) consolidates the orthopedics-focused therapeutic peptide literature, covering bone graft peptides (P-15, BMP-2 mimetics), tendon repair peptides (BPC-157, TB-500), cartilage peptides (Cartalax, anti-myostatin agents), and clinical translation challenges. Cerapedics' PearlMatrix P-15 is highlighted as one of the few FDA-cleared peptide-enhanced orthopedic products — context for the company's Vizient supplier deal earlier this week.